THE WOODLANDS, Texas, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ), today reported financial results for the three months ended June 30, 2025, and provided an update on key corporate milestones and accomplishments.